Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for determining enzyme-inhibiting activity of aminopeptidase N inhibitor and application

A technique for measuring enzyme activity and aminopeptidase, which is applied in the determination/inspection of microorganisms, biochemical equipment and methods, and measuring devices. Accurate, little impact on detection accuracy

Active Publication Date: 2018-12-11
WEIFANG MEDICAL UNIV
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The traditional method of determining the activity of aminopeptidase N enzymes by compounds requires continuous purchase of enzyme standards, which are expensive, prone to failure, and difficult to store

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining enzyme-inhibiting activity of aminopeptidase N inhibitor and application
  • Method for determining enzyme-inhibiting activity of aminopeptidase N inhibitor and application
  • Method for determining enzyme-inhibiting activity of aminopeptidase N inhibitor and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Example 1: Screening for suitable cell carriers.

[0072] In order to improve the accuracy of enzyme activity determination, the present invention investigates the construction of vector cells for protein expression, including K562, PLC, MCF7, A549, and EA.hy926. Count the cells in the logarithmic growth phase after washing, and use 1×10 5 The number of each well was inoculated in a 96-well plate, and the CD13 substrate was added to 1.6mM. Each cell was paralleled to three wells, and the absorbance of the cells was measured at 0h, 0.5h, 1h, and 1.5h, respectively. The results are shown in Table 1:

[0073] Table 1 Luminescence ability of CD13 substrates catalyzed by different cells

[0074]

[0075] It can be seen from the results in Table 1 that K562 cells have the weakest catalytic ability to CD13 substrates, and as an enzyme activity detection tool, they have the least impact on the color development results. The types and quantities of K562 cell membrane surfac...

Embodiment 2

[0076] Example 2: Using the method of the present invention to establish a K562 monoclonal cell line overexpressing CD13.

[0077] 1. Resuspend K562 cells with complete culture medium, inoculate K562 cells in a 96-well plate, 5×10 3 per well, with a volume of 80 μL.

[0078] 2. The stock solution of recombinant lentivirus LV-CD13 is 2×10 8 TU / mL, diluted with ENi.S so that the MOI was 40, 10 μL of recombinant lentivirus LV-CD13 dilution was added to each well, and 10 μL of Polybrene was added as a virus infection auxiliary agent, and cultured overnight.

[0079] 3. Replace the fresh culture medium on the second day to continue the culture, and change the fresh culture medium again on the third day until three days after the recombinant lentivirus LV-CD13 infection, add puromycin to screen the virus-infected K562 cells, and treat the control group cells 2 weeks later. When all the cells died, the culture medium with a concentration of 1.0 mg / mL of puromycin was replaced, and ...

Embodiment 3

[0082] Example 3: Using the method of the present invention to detect the expression level of CD13 by Western Blotting.

[0083] 1. Resuspend K562 and K562-CD13 cells, resuspend K562-CD13 cells and K562 cells, transfer to a centrifuge tube, centrifuge at 1000rpm to remove the supernatant, put on an ice box, add protein lysate, and freeze-thaw fully Cells were lysed, centrifuged at 12000rpm for 15min at 4°C, and the supernatant was taken. Take 5 μL of the supernatant to determine the protein concentration by Bradford method, add the remaining supernatant to an equal volume of 2×loading buffer, heat and boil at 100°C for 5 min to denature the protein. Store at -70°C.

[0084] 2. Add 20 μL, 40 μL, 60 μL, 80 μL, and 100 μL of BSA (1 μg / ml) to 5 test tubes, make up to 1 ml with pure water, and adjust to zero with 1 ml of pure water at the same time, take 50 μL of the lysed whole-cell protein solution, and make up with pure water When the volume reaches 1ml, add 1.4ml of Coomassie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for determining an inhibition ratio of a compound for aminopeptidase N activity. A K562-CD13 cell strain for expressing human source CD13 is taken as an enzyme source for determining the enzyme-inhibiting activity of the compound. The invention also provides a kit for determining the inhibition ratio of the compound for aminopeptidase N activity. The kit is used fordetermining according to the method. According to the technical scheme, the human source CD13 is taken as the enzyme source for evaluating the activity-inhibiting effect of the compound; the accuracyis higher than that of the detection method adopting pig source CD13 in the prior art; the cost is lower and the result is more accurate.

Description

technical field [0001] The invention relates to a method for measuring the enzyme-inhibiting activity of an inhibitor, in particular to a method for measuring the enzyme-inhibiting activity of an aminopeptidase N inhibitor, a method for preparing an enzyme source and an application thereof. Background technique [0002] Aminopeptidase N (Aminopeptidase N, APN / CD13, EC 3.4.11.2) is a zinc ion-dependent transmembrane metalloprotease that localizes on the outer surface of the cell membrane in the form of a homodimer through non-covalent binding. It can hydrolyze oligopeptides, especially degrade neutral amino acids from the N-terminus of the peptide chain. It was first considered as a surface marker of hematopoietic cells in the bone marrow system. It is distributed in various cells and tissues, including hematopoietic cells, fibroblasts , brain tissue cells, liver cells, osteoclasts, endometrial cells, epithelial cells of the liver, kidneys and intestines, synaptic membranes o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/37C12Q1/02
CPCG01N33/502C12Q1/37
Inventor 王学健杨翰林赵燕王雪娟戴功刘慧杰
Owner WEIFANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products